PT - JOURNAL ARTICLE AU - Sarbeswar Praharaj AU - Hoon Han TI - A longitudinal study of the impact of human mobility on the incidence of COVID-19 in India AID - 10.1101/2020.12.21.20248523 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.21.20248523 4099 - http://medrxiv.org/content/early/2020/12/22/2020.12.21.20248523.short 4100 - http://medrxiv.org/content/early/2020/12/22/2020.12.21.20248523.full AB - Human mobility plays a crucial role in determining how fast and where infectious diseases can spread. This study aims to investigate visit to which category of places among grocery, retail, parks, workplaces, residential, and transit stations is more associated with the incidence of COVID-19 in India. A longitudinal analysis of generalized estimating equation (GEE) with a Poisson log-linear model is employed to analyze the daily mobility rate and reported new cases of COVID-19 between March 14 and September 11, 2020. This study finds that mobility to places of grocery (food and vegetable markets, drug stores etc.) and retail (restaurants, cafes, shopping centres etc.) is significantly associated (at p<0.01) with the incidence of COVID-19. In contrast, visits to parks, transit stations and mobility within residential neighbourhoods are not statistically significant (p>0.05) in changing COVID-19 cases over time. These findings highlight that instead of blanket lockdown restrictions, authorities should adopt a place-based approach focusing on vulnerable hotspot locations to contain the COVID-19 and any future infectious disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB/oversight body approval was not necessary as there was no clinical trial and survey conducted. The anonymized data was compiled from an open-source.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe have made the research data available through the Mendeley Data at http://dx.doi.org/10.17632/wpywf5ny6j.1 http://dx.doi.org/10.17632/wpywf5ny6j.1